Cetirizine can cause liver damage, but it is rare. The NIH’s LiverTox database notes that cetirizine is not generally associated with liver enzyme elevations, yet it has been linked to rare instances of clinically apparent liver injury. For the vast majority of people taking cetirizine for allergies, the liver is not a concern. But a small number of documented cases show that it can, unpredictably, cause real problems.
Why Cetirizine Is Usually Easy on the Liver
One reason cetirizine has a strong safety profile is that it barely passes through the liver at all. Only about 8 to 10 percent of the drug is processed by the liver’s main detoxification system. The rest is excreted unchanged through the kidneys. This is unusual for an oral medication and means the liver has very little work to do when you take a standard dose.
Compare that to older antihistamines or many common painkillers, which are heavily processed by the liver and carry a more significant risk of liver stress. Cetirizine’s minimal liver metabolism is a key reason millions of people use it daily without any liver-related side effects.
What the Case Reports Show
Despite that favorable profile, there are roughly a dozen published case reports spanning from 1993 to the present where cetirizine appeared to cause liver injury. These cases ranged from mild enzyme elevations to jaundice and severe hepatitis. The pattern of injury has taken two main forms: direct liver cell damage (hepatitis) and impaired bile flow (cholestasis), where the liver struggles to drain bile properly.
A case series published in Gastroenterology Report documented four patients, ages 21 to 66, who developed liver problems after taking cetirizine for as few as three to seven days. All four showed elevated liver enzymes and symptoms like fatigue and jaundice. In every case, stopping cetirizine led to recovery within two weeks to two months.
Other published cases show a wider timeline. A 23-year-old man developed severe hepatitis nine months after starting cetirizine, with liver enzyme levels spiking to more than 60 times the normal upper limit. He recovered within 44 days of stopping. A 28-year-old man developed cholestatic jaundice two years into cetirizine use, and his recovery was slow and incomplete. In one especially telling case, a 46-year-old man’s jaundice resolved within a month of stopping cetirizine, then returned within 10 days when he restarted the drug, confirming it as the cause.
Among antihistamines as a class, liver injury is uncommon across the board. However, cetirizine is one of the antihistamines most frequently named in these rare reports, alongside cyproheptadine and terfenadine (which has been pulled from the market).
Symptoms to Be Aware Of
In the documented cases, the most common early signs were fatigue, general weakness, and yellowing of the skin or eyes (jaundice). Some patients also experienced nausea. These symptoms appeared anywhere from a few days to several months after starting cetirizine, so there is no single predictable window.
The yellowing of skin and eyes reflects a buildup of bilirubin, a waste product the liver normally clears. When the liver is inflamed or bile flow is blocked, bilirubin accumulates in the bloodstream and becomes visible. If you notice unexplained fatigue or any yellow discoloration while taking cetirizine, it is worth having your liver function checked with a simple blood test.
If You Already Have Liver Disease
People with existing liver conditions process cetirizine more slowly. Studies in patients with chronic liver disease found that the drug’s half-life (the time it takes your body to clear half the dose) increased by about 50 percent, with a corresponding 40 percent decrease in how quickly the body eliminates it. This means the drug lingers longer and reaches higher concentrations.
Because of this, the FDA-approved prescribing information recommends a reduced dose of 5 mg daily (instead of the standard 10 mg) for adults and children 12 and older with liver impairment. A dose reduction is also recommended for children ages 6 to 11 with liver problems. Liver enzymes should be monitored more closely in this group. For children under 6 with impaired liver or kidney function, cetirizine is not recommended.
How This Compares to Other Allergy Medications
All second-generation antihistamines, including loratadine and fexofenadine, have very low rates of liver injury. Cetirizine has slightly more published case reports than the others, but the absolute numbers remain tiny relative to the hundreds of millions of people who have taken it. Fexofenadine is also minimally metabolized by the liver and has an extremely low rate of reported liver problems. If you have a reason to be cautious about liver health, any of the common over-the-counter antihistamines is a reasonable option, but discussing alternatives with a pharmacist or doctor makes sense if you have pre-existing liver disease.
The Bottom Line on Risk
Cetirizine is one of the most widely used allergy medications in the world, and clinically significant liver injury from it is genuinely rare. The documented cases number in the low dozens over three decades of global use. No one has identified a clear mechanism explaining why a small number of people react this way, which means there is no reliable way to predict who is at risk. What the case reports do consistently show is that stopping cetirizine leads to recovery in nearly all affected patients, often within a few weeks. The risk is real but very small, and it should not discourage most people from using cetirizine for allergy relief.